
Developing an education platform for the stem cell industry
We promised we’d keep you updated on our plans, and it’s high time we did. Wideacademy are to launch an alpha version of an innovative Software as a Service (‘SaS’) platform
We promised we’d keep you updated on our plans, and it’s high time we did. Wideacademy are to launch an alpha version of an innovative Software as a Service (‘SaS’) platform
WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announces its interim results for the 6 months ended 30
Widecells Group’s João Andrade and WideAcademy’s Alan Greenberg discuss what WideAcademy is trying to achieve & why, its path to commercialisation and what to expect in the next 6-18 months
Widecells Group Plc (LON:WDC) CEO João Andrade & Vice President of WideAcademy Alan Greenberg talks to DirectorsTalk about the development of a bespoke stem cell focused educational platform to deliver
Wideacademy Director, Alan Greenberg, said, “Since joining Wideacademy in February 2017 we have progressed from vision to strategy and now to commercialisation and materialisation. We have built a platform that
Innovations in healthcare and health technology will change, and prolong, our lives in the coming generations, affecting us in exciting, and accelerating, ways. The work being done in this area
WideCells Group PLC (LON:WDC) CEO João Andrade speaks with Alastair Greener about the changes in stem cell technologies and how the industry is growing year on year. Medical security is
Gill’s Story A diagnosis of blood cancer affects the whole family. At CellPlan we provide a unique protection plan that unlocks world-leading stem cell transplantation and covers the travel and
CellPlan is the world’s first global stem cell healthcare plan, designed to revolutionise stem cell healthcare by making stem cell transplants affordable for families who require treatment for life threatening diseases. WideCells Group’s stem
WideCells Group’s João Andrade discusses the successful placing of £750,000, what it will be used for, the company’s bright future and Widecells being a successful investment opportunity in this exclusive interview with DirectorsTalk